Literature DB >> 7729279

Abnormal sphincter of Oddi response to cholecystokinin in postcholecystectomy syndrome patients with irritable bowel syndrome. The irritable sphincter.

P R Evans1, J F Dowsett, Y T Bak, Y K Chan, J E Kellow.   

Abstract

Standard biliary manometry, including cholecystokinin (CCK) provocation, was performed on 42 consecutive patients (36 F, 6 M, median age 45 years) with postcholecystectomy syndrome (PCS) who had no evidence of organic disease but who had objective clinical features suggesting sphincter of Oddi dysfunction (SOD) (classes I and II). Patients were subdivided into those with (N = 14) and without (N = 28) irritable bowel syndrome (IBS) using a validated symptom questionnaire based on the modified Rome criteria. Resting sphincter of Oddi (SO) motor parameters (basal pressure, contractile amplitude and frequency, and proportion of retrograde contractions), the presence of abnormal manometry, and the presence of an abnormal response to CCK were compared in the two groups. No significant differences in resting parameters of SO motor activity between patients with and without IBS were observed, and abnormal biliary manometry as a whole was not more prevalent in either group (8/13 and 18/27, respectively). An abnormal response to CCK (failure of complete inhibition of phasic contractions), however, was demonstrated in five of 12 patients with IBS compared with only one of 23 patients without IBS (P = 0.01). In patients with postcholecystectomy SOD, an abnormal response of the SO to CCK thus appears to be an important feature of the subset of patients with concomitant IBS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729279     DOI: 10.1007/bf02064214

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Cholecystectomy alters the hormonal response of the sphincter of Oddi.

Authors:  P A Grace; H A Pitt
Journal:  Surgery       Date:  1987-08       Impact factor: 3.982

2.  Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome.

Authors:  J E Kellow; L J Miller; S F Phillips; A R Zinsmeister; J W Charboneau
Journal:  Am J Physiol       Date:  1987-11

3.  Manometric disorders in patients with suspected sphincter of Oddi dysfunction.

Authors:  J Toouli; I C Roberts-Thomson; J Dent; J Lee
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

Review 4.  What is sphincter of Oddi dysfunction?

Authors:  J Toouli
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

5.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients.

Authors:  T L Peeters; G Vantrappen; J Janssens
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

6.  Altered esophageal pain threshold in irritable bowel syndrome.

Authors:  M Costantini; G C Sturniolo; G Zaninotto; R D'Incà; R Polo; R Naccarato; E Ancona
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

7.  Enhanced perception of physiological intestinal motility in the irritable bowel syndrome.

Authors:  J E Kellow; C M Eckersley; M P Jones
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

8.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

9.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

10.  Human fasting and postprandial sphincter of Oddi motility.

Authors:  C S Worthley; R A Baker; J Iannos; G T Saccone; J Toouli
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

View more
  16 in total

1.  Biliary Tract Dysmotility.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

2.  Reversibility of central neuronal changes in patients recovering from gallbladder stones or acute cholecystitis.

Authors:  Daniel-W Kjaer; Marek Stawowy; Lars Arendt-Nielsen; Asbjorn-Mohr Drewes; Peter Funch-Jensen
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

3.  Resolving sphincter of Oddi incontinence for primary duodenal Crohn's disease with strictureplasty.

Authors:  G Alemanno; A Sturiale; F Bellucci; F Giudici; F Tonelli
Journal:  Int J Surg Case Rep       Date:  2012-11-23

4.  Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones.

Authors:  Xun Li; Kexiang Zhu; Lei Zhang; Wenbo Meng; Wence Zhou; Xiangliang Zhu; Bo Li
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 5.  Sphincter of Oddi dysfunction: managing the patient with chronic biliary pain.

Authors:  Lana Bistritz; Vincent G Bain
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 6.  Clinical aspects of sphincter of Oddi function and dysfunction.

Authors:  J Toouli; A Craig
Journal:  Curr Gastroenterol Rep       Date:  1999-04

7.  Discordance of pressure recordings from biliary and pancreatic duct segments in patients with suspected sphincter of Oddi dysfunction.

Authors:  Y K Chan; P R Evans; J F Dowsett; J E Kellow; C A Badcock
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

8.  Small bowel dysmotility in patients with postcholecystectomy sphincter of Oddi dysfunction.

Authors:  P R Evans; Y T Bak; J F Dowsett; R C Smith; J E Kellow
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

9.  Medical treatment for sphincter of oddi dysfunction: can it replace endoscopic sphincterotomy?

Authors:  Véronique Vitton; Salah Ezzedine; Jean-Michel Gonzalez; Mohamed Gasmi; Jean-Charles Grimaud; Marc Barthet
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

Review 10.  Intestinal dysmotility and its relationship to sphincter of Oddi dysfunction.

Authors:  Claudia Sanmiguel; Edy E Soffer
Journal:  Curr Gastroenterol Rep       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.